Search results
Can High Cortisol Levels Cause Weight Gain?
MediaFeed via AOL· 5 days agoElevated cortisol levels can trigger various physical, emotional and behavioral symptoms. (These can indicate other health concerns, though, so keep that...
M&R Capital Management Inc. Has $2.84 Million Holdings in AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 5 days agoM&R Capital Management Inc. reduced its position in AbbVie Inc. (NYSE:ABBV – Free Report) by 0.6% during the 1st quarter, according to the company in its most recent filing with the Securities ...
This Rx-Only Wound Cream Is Like Your Daily Moisturizer on Steroids
Robb Report via Yahoo News· 6 days agoShe added that it can also be prescribed to manage chronic sensitive skin conditions including...
How AI Is Revolutionizing Drug Development
New York Times· 6 days agoIn high-tech labs, workers are generating data to train A.I. algorithms to design better medicine, faster. Steve Lohr reported from the Terray...
Johnson & Johnson (NYSE:JNJ) is Adirondack Trust Co.’s 10th Largest Position
ETF DAILY NEWS· 5 days agoAdirondack Trust Co. cut its position in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 3.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities ...
Hollings Renton Sells 1,950 Shares of AnaptysBio, Inc. (NASDAQ:ANAB) Stock
ETF DAILY NEWS· 5 days agoAnaptysBio, Inc. (NASDAQ:ANAB – Get Free Report) Director Hollings Renton sold 1,950 shares of the business’s stock in a transaction dated Tuesday, June 18th. The stock was sold at an average ...
TREMFYA® (guselkumab) studies underscore its potential to be the only IL-23 inhibitor to offer both...
Morningstar· 4 days agoJohnson & Johnson (NYSE: JNJ) today announced positive topline results from the pivotal Phase 3 GRAVITI investigational study of TREMFYA® (guselkumab) subcutaneous (SC) induction therapy in ...
AbbVie (NYSE:ABBV) Given New $190.00 Price Target at Piper Sandler
ETF DAILY NEWS· 6 days agoAbbVie (NYSE:ABBV – Get Free Report) had its price objective boosted by research analysts at Piper Sandler from $185.00 to $190.00 in a research note issued on Tuesday, Benzinga reports. Piper ...
In a 'gold rush' for treating bowel disease, AbbVie clears one more stage
Crain s Chicago Business· 4 days agoWith the arrival of biosimilar competition for its blockbuster drug Humira, AbbVie has said much of its sales growth potential lies with these two anti-inflammatories. In April, the North Chicago ...
Doctors Share What Foods You Should Be Eating To Look 'Healthier And More Youthful'—Plus Which Foods...
SheFinds via Yahoo News· 6 days agoAs we welcome summer weather, doctors and skincare experts stress that it’s crucial to keep yourself...
